VBI Vaccines Inc/BC Quarterly Liabilities and Equity in USD from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
VBI Vaccines Inc/BC quarterly Liabilities and Equity history and growth rate from Q4 2015 to Q1 2024.
  • VBI Vaccines Inc/BC Liabilities and Equity for the quarter ending March 31, 2024 was $75.4M, a 41.3% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $75.4M -$53M -41.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $87M -$68.1M -43.9% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $101M -$71.2M -41.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $88.3M -$83.8M -48.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $128M -$65.5M -33.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $155M -$55.2M -26.2% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $172M -$52.2M -23.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $172M -$52.5M -23.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $194M -$28.9M -13% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $210M +$904K +0.43% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $224M +$24.7M +12.4% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $225M +$63.4M +39.4% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $223M +$116M +108% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $209M +$87.2M +71.3% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $200M +$67.6M +51.3% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $161M +$46.5M +40.6% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $107M -$19M -15.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $122M -$15.4M -11.2% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $132M +$23.1M +21.2% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $115M -$5.04M -4.21% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $126M -$8.58M -6.36% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $138M -$8.05M -5.53% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $109M +$20.3M +23% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $120M +$27.7M +30.1% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $135M +$37.8M +39% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $146M +$40.9M +39% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $88.5M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $92M Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $97M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $105M +$87.7M +515% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $17M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.